AbbVie Inc

Company Profile

AbbVie Inc had its IPO on 2013-01-02 under the ticker symbol ABBV.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. AbbVie Inc has a staff strength of 50,000 employees.

Stock update

Shares of AbbVie Inc opened at $149.5 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $147.62 - $149.6, and closed at $149.27.

This is a +0.15% increase from the previous day's closing price.

A total volume of 1,853,169 shares were traded at the close of the day’s session.

In the last one week, shares of AbbVie Inc have increased by +0.72%.

AbbVie Inc's Key Ratios

AbbVie Inc has a market cap of $266.26 billion, indicating a price to book ratio of 18.2288 and a price to sales ratio of 4.9887.

In the last 12-months AbbVie Inc’s revenue was $58.05 billion with a gross profit of $41.53 billion and an EBITDA of $31.09 billion. The EBITDA ratio measures AbbVie Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, AbbVie Inc’s operating margin was 38.97% while its return on assets stood at 9.91% with a return of equity of 72.39%.

In Q4, AbbVie Inc’s quarterly earnings growth was a negative -38.8% while revenue growth was a positive 1.6%.

AbbVie Inc’s PE and PEG Ratio

Forward PE

14.3885

Trailing PE

22.6968

PEG

1.2788

Its diluted EPS in the last 12-months stands at $6.63 per share while it has a forward price to earnings multiple of 14.3885 and a PEG multiple of 1.2788. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into AbbVie Inc’s profitability.

AbbVie Inc stock is trading at a EV to sales ratio of 6.0409 and a EV to EBITDA ratio of 13.7968. Its price to sales ratio in the trailing 12-months stood at 4.9887.

AbbVie Inc stock pays annual dividends of $5.71 per share, indicating a yield of 3.81% and a payout ratio of 41.41%.

Balance sheet and cash flow metrics

Total Assets

$138.81 billion

Total Liabilities

$29.54 billion

Operating Cash Flow

$-448000000.00

Capital Expenditure

$213 million

Dividend Payout Ratio

41.41%

AbbVie Inc ended 2025 with $138.81 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $138.81 billion while shareholder equity stood at $17.25 billion.

AbbVie Inc ended 2025 with $2.19 billion in deferred long-term liabilities, $29.54 billion in other current liabilities, 18000000.00 in common stock, $4.78 billion in retained earnings and $32.16 billion in goodwill. Its cash balance stood at $9.20 billion and cash and short-term investments were $9.23 billion. The company’s total short-term debt was $4,136,000,000 while long-term debt stood at $59.14 billion.

AbbVie Inc’s total current assets stands at $28.46 billion while long-term investments were $241.00 million and short-term investments were $28.00 million. Its net receivables were $11.25 billion compared to accounts payable of $25.40 billion and inventory worth $3.58 billion.

In 2025, AbbVie Inc's operating cash flow was $-448000000.00 while its capital expenditure stood at $213 million.

Comparatively, AbbVie Inc paid $0.41 in dividends in 2025.

Other key metrics

Current Trading Price

$149.27

52-Week High

$169.4595

52-Week Low

$131.4894

Analyst Target Price

$163.22

AbbVie Inc stock is currently trading at $149.27 per share. It touched a 52-week high of $169.4595 and a 52-week low of $169.4595. Analysts tracking the stock have a 12-month average target price of $163.22.

Its 50-day moving average was $145.02 and 200-day moving average was $148.06 The short ratio stood at 1.87 indicating a short percent outstanding of 0%.

Around 11.8% of the company’s stock are held by insiders while 7152.7% are held by institutions.